Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (41-50 of 393) with videos related to

Pageof 40
Sort By:
Frontiers in Oncology|December 19, 2017
Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated LiposarcomaYevette McGovern, Charlie D Zhou, Robin L Jones
Future Oncology (London, England)|December 6, 2016
Treatment of soft tissue sarcoma: a focus on earlier stagesAlessandro Gronchi, Robert G Maki, Robin L Jones
Expert Opinion on Drug Safety|October 19, 2006
Anthracycline cardiotoxicityRobin L Jones, Charles Swanton, Michael S Ewer
Journal of Medical Case Reports|May 17, 2011
Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case reportMichelle Cm Cheung, Robin L Jones, Ian Judson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2024
First-Line Tyrosine Kinase Inhibitors in Soft-Tissue Sarcomas: A Role for Anlotinib?Andrea Napolitano, Paul H Huang, Robin L Jones
Future Oncology (London, England)|June 11, 2020
Avapritinib in the treatment of PDGFRA exon 18 mutated gastrointestinal stromal tumorsAlannah Smrke, Spyridon Gennatas, Paul Huang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
The Current Landscape of Early Drug Development for Patients With SarcomaBreelyn A Wilky, Robin L Jones, Vicki L Keedy
Future Oncology (London, England)|July 6, 2021
Desmoid fibromatosis: is the current picture changing?Saneya Pandrowala, Robin L Jones, Sanjay Gupta, et al.
Annals of Diagnostic Pathology|November 4, 2016
Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategiesKhin Thway, Jonathan Noujaim, Robin L Jones, et al.
Expert Review of Anticancer Therapy|August 26, 2010
Beyond triple-negative breast cancer: the need to define new subtypesAnastasia Constantinidou, Robin L Jones, Jorge S Reis-Filho
Pageof 40

Showing results (41-50 of 393) with videos related to

Sort By:
Pageof 40
Frontiers in Oncology|December 19, 2017
Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated LiposarcomaYevette McGovern, Charlie D Zhou, Robin L Jones
Future Oncology (London, England)|December 6, 2016
Treatment of soft tissue sarcoma: a focus on earlier stagesAlessandro Gronchi, Robert G Maki, Robin L Jones
Expert Opinion on Drug Safety|October 19, 2006
Anthracycline cardiotoxicityRobin L Jones, Charles Swanton, Michael S Ewer
Journal of Medical Case Reports|May 17, 2011
Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case reportMichelle Cm Cheung, Robin L Jones, Ian Judson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2024
First-Line Tyrosine Kinase Inhibitors in Soft-Tissue Sarcomas: A Role for Anlotinib?Andrea Napolitano, Paul H Huang, Robin L Jones
Future Oncology (London, England)|June 11, 2020
Avapritinib in the treatment of PDGFRA exon 18 mutated gastrointestinal stromal tumorsAlannah Smrke, Spyridon Gennatas, Paul Huang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
The Current Landscape of Early Drug Development for Patients With SarcomaBreelyn A Wilky, Robin L Jones, Vicki L Keedy
Future Oncology (London, England)|July 6, 2021
Desmoid fibromatosis: is the current picture changing?Saneya Pandrowala, Robin L Jones, Sanjay Gupta, et al.
Annals of Diagnostic Pathology|November 4, 2016
Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategiesKhin Thway, Jonathan Noujaim, Robin L Jones, et al.
Expert Review of Anticancer Therapy|August 26, 2010
Beyond triple-negative breast cancer: the need to define new subtypesAnastasia Constantinidou, Robin L Jones, Jorge S Reis-Filho
Pageof 40